Blog

MATTER and rMark Bio Launch Startup Industry Innovation Matchmaker

MATTER and rMark Bio Launch Startup Industry Innovation Matchmaker

CHICAGOMay 7, 2019

MATTER, the premier healthcare incubator and innovation hub, and rMark Bio, an industry-leading life sciences AI company and a MATTER member since 2016, today announced the launch of Origin™. Exclusively available to MATTER’s startup members and partner organizations, Origin combines the power of machine learning with MATTER’s expertise in vetting, coaching and convening to accelerate innovation via collaboration.

“MATTER works with entrepreneurs who are developing solutions that can meaningfully improve health and healthcare, and we work with established organizations that need innovative ideas,” said MATTER CEO Steven Collens. “We help the right people find each other at the right time, so they can collaborate on developing and implementing solutions that improve health and care.”

Built on rMark Bio’s machine learning platform, Fabric™, Origin is an intelligent matchmaking engine that connects pharmaceutical companies, payers and health systems with the right startup collaborators. Every match recommended by Origin is validated by MATTER before facilitating the right kind of introduction so that every collaboration is set up for success.

“Through MATTER, we had the opportunity to make the right connection at exactly the right time in rMark Bio’s development,” said Jason Smith, co-founder and CEO of rMark Bio. “Origin is designed to scale opportunities like ours. We’re using best-in-class modeling to help MATTER cut through the noise and optimize opportunities for startups and large organizations alike.”

Origin is now available.

About MATTER

At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes 200 cutting-edge startups from around the world, working together with hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives. For more information, visit matter.health and follow @MATTERhealth.

Keep up to date with rMark by following us on our social channels:

rMark Bio’s Fabric™: Scalable AI Solution Helps Life Sciences Companies Accelerate Drug Discovery, Collaboration and Development

rMark Bio’s Fabric™: Scalable AI Solution Helps Life Sciences Companies Accelerate Drug Discovery, Collaboration and Development

CHICAGOMarch 18, 2019 /PRNewswire/ – rMark Bio announces the launch of Fabric™, an advanced end-to-end AI solution that delivers personalized business intelligence through integrated applications and API accessible services that are built to solve common scientific and business challenges within life sciences organizations.

“While AI and machine learning hold transformational promise for life sciences companies, they struggle to make it a reality because the issues are complex with numerous divisions, needs and a plethora of data inputs. There is no one-size-fits-all solution, Fabric addresses key business needs of life sciences companies through intelligent, modular services that are accessible via our Fabric APIs. Fabric provides life sciences companies customizable solutions that strategically mine internal, third party and public data, align priorities across the organization and connect them to key opinion leaders and health care providers to help them address their evolving needs.”

Jason Smith

Co-Founder & CEO, rMark Bio.

Fabric is designed to analyze petabytes of unstructured text, videos, voice, proteomics, genomic and free form data from existing business applications such as Microsoft™, Salesforce™ and Veeva™ along with third party data sources from IQVIA™ and Symphony Heath™.  Working in unison, Fabric’s neural networks determine the most relevant insights and discoveries and then shape them based on each department or user’s specific business needs without the requirement of multiple systems.

Fabric can be tailored to address issues faced by specific divisions across an organization. Life sciences companies can utilize Fabric’s agility in a variety of ways. Customers use Fabric’s data service to enrich their data with public sources, automating quality control and preparing it for machine learning. Other customers leverage Fabric ML’s data intelligence to build new insights and shape them into business decisions or recommendations.

rMark Bio offers companies myriad ways to partner, build and collaborate with us to empower transformation across multiple departments,” said Smith.

Today, customers adopt Fabric offerings in a multitude of ways, for example:

 

  • Top-10 pharmaceutical companies are collaborating with rMark to build custom applications based on a combination of Fabric APIs and Machine Learning.
  • Companies buy a customizable out-of-the-box solution such as Cue™, an AI “matchmaking” assistant that uses machine learning to help companies discover, build and manage relationships with health care providers active in areas relevant to their interests and imperatives.
  • Companies bring their existing CRM, messaging or internal business applications and integrate with Fabric’s platform and APIs to deliver insightful, time-saving insights.

“Fabric APIs are designed specifically with life sciences companies in mind. Our strategy is to enable these companies and their teams to benefit from Fabric’s ML without always needing to incorporate another app into their workflow.  By delivering intelligence via products that teams already use – be it chat, email, a CRM, voice or others – we can surface the right insights at the right time within the products they use most frequently. For those who require an app, we offer an out of the box solution, but Fabric Services also solves a real issue in digital transformation as a whole — app overload, which can lead to lack of engagement and decreased productivity.”

Jason Smith

Co-Founder & CEO, rMark Bio.

rMark Bio has opened Fabric to select product companies to build and sell their own offerings for the life sciences industry. OpX Insights built its flagship product VoKOL™ using Fabric’s NLP services and Field Insights APIs, which enhances the ability of medical affairs to capture and report on scientific insights from field teams. VoKOL optimizes scientific exchange by collecting current strategies in one place, enabling a quick dive into individual strategies for reporting, trending and analysis and then providing intelligent alerts based on field insights.

“Fabric enabled us to rapidly develop a solution that helps analyze insights, identify new strategies and transform data into actionable tactics for medical professionals,” said Mike Abbadessa, PharmD, CEO and Founder of OpX Insights. “Building on this industry-leading solution meant we could accelerate our time to market.”

Abbadessa of OpX Insights will be joining rMark Bio for a live demo of VoKOL and Fabric at booth 307 at the DIA Medical Affairs and Scientific Communications Forum March 18-20 in Orlando, Fla.

Keep up to date with rMark by following us on our social channels:

Annette Thurston To Lead Product At rMark Bio

Annette Thurston To Lead Product At rMark Bio

Will Leverage Wealth of Experience to Drive Solutions Strategy

CHICAGOMarch 11, 2019 /PRNewswire/ — rMark Bio, which delivers AI solutions that accelerate innovation, collaboration and scientific discoveries for life sciences companies, is pleased to announce that Annette Thurston has joined the company as its vice president of product. With a wealth of experience delivering world-class products for Fortune 500 companies, extensive multidisciplinary practice in product management and foundational knowledge in design, Thurston will define and drive the company’s product strategy, execution and delivery.

Thurston, who has been advising rMark Bio since its inception four years ago, will leverage her experience in delivering products for global brands such as adidas, AT&T and Allstate as she forges rMark Bio’s product-first methodology.

“It’s an exciting time to be part of such a visionary company. rMark Bio is leading the way in helping life sciences companies solve challenging problems by capitalizing on machine learning and AI insights,” said Thurston. “This is a fascinating area of digital transformation. Being part of rMark Bio’s team gives me the opportunity to build products that facilitate in ultimately improving lives. It’s purposeful work.”

“I’ve known and worked with Annette for more than five years and have always been impressed with her insight and vision, I’m confident that she’ll accelerate rMark Bio’s product development and thought leadership. She has an uncanny ability to look at the marketplace, perceive where the needs are and drive creation of products that solve problems. That’s invaluable.”

Jason Smith

Co-Founder & CEO, rMark Bio.

Thurston practices less is more when it comes to products. Noting that technology should make our lives easier, not more complicated, she is focused on building solutions that integrate harmoniously with existing technologies to reduce digital noise and improve how people work and live.

Prior to joining rMark Bio, Thurston led consumer products at Arity, a connected car company subsidiary of Allstate.

About rMark Bio
rMark Bio Inc. was created to transform the life sciences and pharmaceutical industries by making artificial intelligence simple to adopt, easy to use and continuously transformative through a holistic approach incorporating strategy, technology and people power. Founded in 2015 by Jason M. Smith, CEO, and Lev Becker, Ph.D., Chief Scientist, rMark Bio is based in Chicago and Seattle. rMark Bio provides services to the top 20 pharmaceutical companies globally and has partnered with industry-leading technology and healthcare organizations, including Microsoft, nVidia, Apigee/Google, and MATTER.

Keep up to date with rMark by following us on our social channels:

Life Sciences AI Company rMark Bio Raises $1.5 Million In Seed Funding

Life Sciences AI Company rMark Bio Raises $1.5 Million In Seed Funding

rMark Bio has recently closed $1.5 million in growth funding. Lincoln Park Capital led the Seed funding along with support from investors M25 Group, SaaS Ventures and MATH Venture Partners.

“We appreciate that investors recognize our unique value proposition. Our ability to help accelerate innovation, especially in highly complex life sciences fields such as therapeutic development, by effectively analyzing and aligning internal and external data with their business strategies, means we help them bring their data to life for the ultimate benefit of patients. This vital funding ensures we are able to expand our ability to bring our end-to-end intelligence solutions to companies that want to harness the transformative power of their data but struggle with how to make it a reality.”

Jason Smith

Co-Founder & CEO, rMark Bio.

With the close of investment, MATH Venture Partners Managing Director Mark Achler has also joined our Board of Directors. 

 

“I’m excited to be part of an AI venture that can help accelerate discovery and innovations within the life sciences and the healthcare industry. Jason and his team understand how to build AI in order to help define and deliver data-driven insights.”

Mark Arhler

Managing Director, MATH Venture Partners

The funding will be used to grow rMark Bio through market expansion, enable the hiring of key personnel and support rMark Bio’s transition into its new headquarters office at 440 N. Wells in Chicago.

Fabric, rMark Bio’s patented platform, is an end-to-end AI solution that accelerates innovation and scientific discoveries for life sciences companies by fostering awareness and collaboration. The Fabric platform employs several key capabilities in a three-step process:

1. It enables automated aggregation and preparation of data for machine learning.

2. Neural networks are trained to analyze data and surface scientific insights and discoveries.

3. Fabric’s APIs integrate with existing apps to deliver insights.

Specifically, Fabric is trained to understand petabytes of life sciences unstructured text, videos, voice, proteomics, genomic and free form data from existing business applications such as Microsoft™, Salesforce™ and Veeva™ along with third party data sources from IQVIA™ and Symphony Heath™. Working in unison, Fabric’s neural networks surface the most relevant insights and discoveries based on each department or user’s specific business needs, without the cost of multiple systems.

Fabric currently is licensed and deployed in several top-20 pharmaceutical companies who are benefitting from savings with its unified data intelligence solution. For example, rMark Bio is saving one customer millions of dollars during the next 12 months compared to what it would have spent for traditional SaaS or consulting services.

“Ahead of that customer’s product launch, the Fabric platform provided its marketing department and commercial sales leadership with one-click access to real-time, compliant and, most importantly, relevant target lists.”

Jason Smith

Co-Founder & CEO, rMark Bio.

Keep up to date with rMark by following us on our social channels:

Accenture & MATTER: Digital Health & Life Sciences Pitch Competition

Accenture & MATTER: Digital Health & Life Sciences Pitch Competition

CHICAGONovember 9, 2018 

Accenture and MATTER for their first annual Digital Health & Life Sciences Pitch Competition. This competition will feature some of Chicago’s most promising healthcare startups pitching to C-Suite leaders in the provider and life sciences industries and vying for the winning prize.

Startups Included:

  • rMark Bio
  • Prepared Health
  • ExplORer Surgical
  • Markit Medical
  • Seurat Therapeutics

Date And Time

Fri, November 9, 2018

3:30 PM – 5:30 PM CST

Sign up here!

Location:

MATTER, 222 Merchandise Mart Plaza Suite 1230 Chicago, IL 60654

Keep up to date with rMark by following us on our social channels:

AI Days Startup Bootcamp Preview

AI Days Startup Bootcamp Preview

Join Jason Smith and our team at the upcoming AI Days event. Jason will be discussing rMark Bio’s journey in the development of our AI platform for the life science industry.

There will also be a panel of three AI Leaders talking about three new aspects of building an AI startup! Attend this second installment of the AI Startup Bootcamp introduction.

Learn the steps of building AI value propositions | Drive your AI startup forward | Network with the largest AI startup group in Chicago.

This event is a preview of AI Days (http://www.chicagoaidays.com). It will feature a full day AI startup bootcamp, AI startup weekend and many other sessions.

GENERAL PROGRAM OUTLINE.

Between May 21, July 24 and August Meetups most of these topics will be covered:

1) Data : how to acquire ; build a model and validate
2) Team: Data scientists, developers, domain experts, UX
3) AI stack: Infrastructure/cloud, analytics, applications, open source, visualization
4) Solution Architecture : platforms, workflows, integration
5) Go To Market: channel, industry, testing, value proposition, customer validation, pricing
6) Funding: valuation, term sheet, presentation, pitch
7) Other : Explainability, Hardware, Ethics, Productizing, IP, mentoring, Other

AGENDA

5:30 to 6PM – Networking

6PM to 7PM – Key pointers on how to build an AI startup

     6:00 – AI Stack by Yueyu Fu of Rippleshot
     6:20 – Solution Architecture by Jason Smith of rMark Bio
     6:40 – Funding by Brian Clark of Ascent Regtech 

7PM to 7:45 Panel discussion : Opportunities and Challenges in building AI Startups

     Panelists are Jason Smith, Yueyu Fu and Brian Clark.

7:45 to 8:30PM Networking

Date And Time

Tuesday, July 24, 2018
5:30 PM
 to 8:00 PM

Location:

Tech Nexus, 20 N. Wacker Drive, Suite 1200 · Chicago, IL

Keep up to date with rMark by following us on our social channels:

Video: Jason Smith Discusses Platform Development with Apigee

Video: Jason Smith Discusses Platform Development with Apigee

Hear from Jason Smith, CEO and co-founder of rMark Bio, Inc., about how his company used Apigee to optimize their expansion when they were growing as a startup.

rMark Bio is a Chicago-based software company focused on building the world’s first deep learning recommendation and analytics platform specifically for pharmaceutical companies. In their early stages, rMark Bio were able to rely on Apigee for full life cycle API management, freeing up time and energy to be spent on further developing their product. Jason explains how he leveraged Apigee to grow smoothly as a start up, and how his company built their analytics framework by leaning on and integrating with the Apigee platform.

Learn more at the Apigee resources page → http://bit.ly/2JE3qnI

Subscribe to the Apigee YouTube channel → http://bit.ly/Apigee

Keep up to date with rMark by following us on our social channels:

rMark Bio CEO Podcast with Microsoft

rMark Bio CEO Podcast with Microsoft

A DATING APP FOR THE MEDICAL INDUSTRY

Listen to rMark Bio CEO, Jason Smith, discuss technology, AI and Chicago with Martin Schray on Microsoft’s Series A Podcast.

The podcast asks: What do you get when you combine a seasoned serial entrepreneur and technologist with a PhD and tenure track cancer researcher at the University of Chicago? One of the most promising startups disrupting the healthcare industry.

Keep up to date with rMark by following us on our social channels:

Dr. Gayle Kirkpatrick Joins rMark Bio’s-Advisory Board

Dr. Gayle Kirkpatrick Joins rMark Bio’s-Advisory Board

We would like to welcome, former Abbott/AbbVie Exec, Dr. Gayle Kirkpatrick, as she joins rMark Bio’s Advisory Board. Dr. Kirkpatrick is an accomplished executive with 25+ years of experience in Fortune 100 healthcare corporations and major academic research institutions. Her expertise and and former contributions to strategic planning, industry analysis, and due diligence for previous clients from early stage biotechnology companies to fully integrated pharmaceutical companies will be invaluable. 

PRESS RELEASE:

“CHICAGOFeb. 8, 2018 /PRNewswire/ — rMark Bio is pleased to announce that Dr. Gayle Kirkpatrick has joined their Advisory board. The Chicago-based life science SaaS company, which delivers a suite of thought leader engagement applications atop their patented analytics platform, is elated to work with Gayle. Working alongside rMark Bio’s leadership team, Gayle is committed to developing plans to expand the adoption of their business intelligence solution for biopharmaceutical and other companies around the world.”

Read more here…

Markets Insider

https://markets.businessinsider.com

Keep up to date with rMark by following us on our social channels:

Chicago Inno Highlights rMark Bio’s Take on Innovation

Chicago Inno Highlights rMark Bio’s Take on Innovation

Last Wednesday, Chicago Inno posted an article highlighting rMark’s KOL technology. Chicago Inno is an online publication local to the Chicago area. They have been covering Chicago’s entrepreneurial ecosystem since 2014. Focussing on connecting and producing digital media and local events.

Chicago Inno is part of the greater Inno network, cultivating national audience of next-gen business leaders and assembling a network of local innovation expertise. 

This Chicago Startup Aims to Bring Deep Learning to the Pharma Industry

Chicago Inno

https://www.americaninno.com/chicago

Keep up to date with rMark by following us on our social channels:

rMark Bio & Takeda

rMark Bio & Takeda

A challenge for any startup is gaining a deep understanding of your customer’s needs and pain points.  At rMark Bio, Jason and Lev were fortunate enough to learn and adapt early on with our first customer, Takeda.  Our friends at MATTER did a great job capturing the story of how our relationship with Takeda evolved and ultimately led to signing Takeda as rMark Bio’s first customer – How a One-year Old Startup Tackled an Industry Giant’s Problem

A special thank you to entire MATTER team for their on-going support!